ROCHE FDA Approval NDA 021087

NDA 021087

ROCHE

FDA Drug Application

Application #021087

Documents

Letter2000-11-17
Letter2009-11-05
Letter2009-10-16
Letter2009-10-19
Letter2005-04-28
Letter2005-11-01
Letter2005-08-19
Letter2009-10-19
Letter2009-10-19
Letter2006-01-18
Letter2009-10-19
Letter2007-07-05
Letter2007-12-18
Letter2009-10-19
Letter2010-02-26
Letter2011-03-24
Letter2014-11-28
Letter2013-01-29
Letter2012-12-21
Letter2014-06-03
Label2001-07-24
Label2001-07-24
Label2004-07-01
Label2005-11-01
Label2005-08-19
Label2006-01-10
Label2006-11-14
Label2010-12-16
Label2010-03-03
Label2010-11-05
Label2011-03-23
Label2012-08-17
Label2013-08-12
Label2014-10-15
Review2007-06-18
Review2004-04-14
Review2007-06-18
Review2007-06-18
Review2007-06-22
Review2007-06-22
Review2007-06-22
Review2007-06-22
Review2013-06-03
Review2013-06-03
Review2013-04-08
Patient Package Insert2006-01-10
Letter1999-10-27
Letter2002-04-26
Letter2009-11-05
Letter2004-07-01
Letter2009-11-05
Letter2009-10-19
Letter2009-10-19
Letter2009-10-19
Letter2009-10-19
Letter2006-11-16
Letter2009-10-19
Letter2009-10-21
Letter2009-10-19
Letter2009-10-21
Letter2009-10-21
Letter2009-10-21
Letter2007-10-10
Letter2008-01-18
Letter2009-10-19
Letter2010-12-21
Letter2009-04-29
Letter2010-02-26
Letter2010-11-10
Letter2011-02-09
Letter2012-08-20
Letter2014-10-16
Letter2016-06-22
Label1999-10-27
Label2000-11-17
Label2001-07-24
Label2003-04-22
Label2002-04-26
Label2005-04-28
Label2007-07-05
Label2007-10-10
Label2008-01-18
Label2009-04-29
Label2010-03-03
Label2011-02-07
Label2014-12-03
Label2012-12-21
Label2014-06-03
Label2016-06-21
Review2001-05-29
Review2007-06-22
Review2007-06-22
Review2007-06-22
Review2007-06-22
Review2007-06-22
Review2014-07-07
Review2015-07-21
Review2015-07-20
Patient Package Insert2006-11-14
Other Important Information from FDA2006-12-13
Other2013-08-12
Summary Review2012-12-21
Pediatric Medical Review1900-01-01
Pediatric Written Request1900-01-01
Letter2018-04-06
Label2018-04-13
Label2018-12-19
Letter2018-12-19
Label2019-08-05
Letter2019-08-05
Pediatric Amendment 11900-01-01

Application Sponsors

NDA 021087ROCHE

Marketing Status

Prescription001
Prescription002
Prescription003

Application Products

001CAPSULE;ORALEQ 75MG BASE1TAMIFLUOSELTAMIVIR PHOSPHATE
002CAPSULE;ORALEQ 45MG BASE1TAMIFLUOSELTAMIVIR PHOSPHATE
003CAPSULE;ORALEQ 30MG BASE1TAMIFLUOSELTAMIVIR PHOSPHATE

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP1999-10-27PRIORITY
EFFICACY; EfficacySUPPL2AP2000-11-17PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL3AP2000-11-09PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL4AP2001-03-06PRIORITY
LABELING; LabelingSUPPL5AP2001-07-24PRIORITY
LABELING; LabelingSUPPL6AP2001-07-24STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL7AP2001-07-13PRIORITY
LABELING; LabelingSUPPL8AP2001-07-24STANDARD
LABELING; LabelingSUPPL9AP2001-11-05STANDARD
LABELING; LabelingSUPPL10AP2002-04-26STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL11AP2002-03-28PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL12AP2002-05-07PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL13AP2003-03-10PRIORITY
EFFICACY; EfficacySUPPL14AP2003-02-14PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL15AP2003-02-28PRIORITY
LABELING; LabelingSUPPL16AP2004-06-24STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL17AP2004-04-26PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL18AP2004-04-24PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL19AP2004-08-12PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL20AP2004-10-19PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL21AP2005-01-18PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL23AP2005-04-20PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL24AP2005-05-19PRIORITY
LABELING; LabelingSUPPL25AP2005-10-27STANDARD
LABELING; LabelingSUPPL26AP2005-08-16STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL27AP2005-10-14PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL28AP2005-10-14PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL29AP2005-12-01PRIORITY
EFFICACY; EfficacySUPPL30AP2005-12-21UNKNOWN
MANUF (CMC); Manufacturing (CMC)SUPPL31AP2006-06-23PRIORITY
LABELING; LabelingSUPPL33AP2006-11-13STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL34AP2006-12-19PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL35AP2007-02-01PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL36AP2007-02-27PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL37AP2007-03-12PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL38AP2007-03-22PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL39AP2007-03-26PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL40AP2007-07-02N/A
LABELING; LabelingSUPPL41AP2007-10-05STANDARD
LABELING; LabelingSUPPL42AP2008-01-17STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL43AP2008-05-05PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL44AP2007-12-03PRIORITY
LABELING; LabelingSUPPL45AP2010-12-15STANDARD
LABELING; LabelingSUPPL46AP2008-06-10STANDARD
LABELING; LabelingSUPPL47AP2008-09-25STANDARD
LABELING; LabelingSUPPL48AP2010-02-22STANDARD
EFFICACY; EfficacySUPPL49AP2010-02-22PRIORITY
LABELING; LabelingSUPPL55AP2010-11-05STANDARD
LABELING; LabelingSUPPL56AP2011-03-21STANDARD
LABELING; LabelingSUPPL57AP2011-02-07901 REQUIRED
LABELING; LabelingSUPPL59AP2012-08-16STANDARD
LABELING; LabelingSUPPL60AP2014-11-26STANDARD
LABELING; LabelingSUPPL61AP2013-01-29STANDARD
EFFICACY; EfficacySUPPL62AP2012-12-21PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL63AP2013-12-20PRIORITY
LABELING; LabelingSUPPL64AP2014-05-30STANDARD
LABELING; LabelingSUPPL65AP2014-10-14STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL66AP2014-10-08PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL67AP2014-12-15PRIORITY
LABELING; LabelingSUPPL68AP2016-06-20STANDARD
LABELING; LabelingSUPPL69AP2018-04-04STANDARD
LABELING; LabelingSUPPL70AP2018-12-12STANDARD
EFFICACY; EfficacySUPPL71AP2019-08-02STANDARD

Submissions Property Types

SUPPL1Null0
SUPPL3Null0
SUPPL4Null0
SUPPL5Null0
SUPPL7Null0
SUPPL11Null0
SUPPL12Null0
SUPPL13Null0
SUPPL14Null0
SUPPL15Null0
SUPPL16Null8
SUPPL17Null0
SUPPL18Null0
SUPPL19Null0
SUPPL20Null0
SUPPL21Null0
SUPPL23Null0
SUPPL24Null0
SUPPL27Null0
SUPPL28Null0
SUPPL29Null0
SUPPL31Null0
SUPPL34Null0
SUPPL35Null0
SUPPL36Null0
SUPPL37Null0
SUPPL38Null0
SUPPL39Null0
SUPPL40Null4
SUPPL43Null0
SUPPL44Null0
SUPPL45Null6
SUPPL48Null6
SUPPL49Null6
SUPPL55Null7
SUPPL56Null6
SUPPL57Null6
SUPPL59Null15
SUPPL60Null6
SUPPL61Null6
SUPPL62Null7
SUPPL63Null0
SUPPL64Null15
SUPPL65Null15
SUPPL66Null0
SUPPL67Null0
SUPPL68Null15
SUPPL69Null6
SUPPL70Null7
SUPPL71Null7

TE Codes

001PrescriptionAB
002PrescriptionAB
003PrescriptionAB

CDER Filings

ROCHE
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 21087
            [companyName] => ROCHE
            [docInserts] => ["",""]
            [products] => [{"drugName":"TAMIFLU","activeIngredients":"OSELTAMIVIR PHOSPHATE","strength":"EQ 75MG BASE","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"Yes"},{"drugName":"TAMIFLU","activeIngredients":"OSELTAMIVIR PHOSPHATE","strength":"EQ 45MG BASE","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"TAMIFLU","activeIngredients":"OSELTAMIVIR PHOSPHATE","strength":"EQ 30MG BASE","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"}]
            [labels] => [{"actionDate":"08\/02\/2019","submission":"SUPPL-71","supplementCategories":"Efficacy-Labeling Change With Clinical Data","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/021087s071,021246s054lbl.pdf\"}]","notes":""},{"actionDate":"12\/12\/2018","submission":"SUPPL-70","supplementCategories":"Labeling-Patient Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"\"}]","notes":""},{"actionDate":"12\/12\/2018","submission":"SUPPL-70","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"\"}]","notes":""},{"actionDate":"04\/04\/2018","submission":"SUPPL-69","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/021087s069,021246s052lbl.pdf\"}]","notes":""},{"actionDate":"06\/20\/2016","submission":"SUPPL-68","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/021087s068,021246s051lbl.pdf\"}]","notes":""},{"actionDate":"06\/20\/2016","submission":"SUPPL-68","supplementCategories":"Labeling-Patient Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/021087s068,021246s051lbl.pdf\"}]","notes":""},{"actionDate":"11\/26\/2014","submission":"SUPPL-60","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/021087s060,021246s043lbl.pdf\"}]","notes":""},{"actionDate":"10\/14\/2014","submission":"SUPPL-65","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/021087s065,021246s048lbl.pdf\"}]","notes":""},{"actionDate":"05\/30\/2014","submission":"SUPPL-64","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/021087s064,021246s047lbl.pdf\"}]","notes":""},{"actionDate":"01\/29\/2013","submission":"SUPPL-61","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/021087s061,021246s044lbl.pdf\"}]","notes":""},{"actionDate":"01\/29\/2013","submission":"SUPPL-61","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/021087s061,021246s044lbl.pdf\"}]","notes":""},{"actionDate":"01\/29\/2013","submission":"SUPPL-61","supplementCategories":"Labeling-Patient Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/021087s061,021246s044lbl.pdf\"}]","notes":""},{"actionDate":"12\/21\/2012","submission":"SUPPL-62","supplementCategories":"Efficacy-New Patient Population","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2012\\\/021087s062lbl.pdf\"}]","notes":""},{"actionDate":"08\/16\/2012","submission":"SUPPL-59","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2012\\\/021087s059,021246s042lbl.pdf\"}]","notes":""},{"actionDate":"03\/21\/2011","submission":"SUPPL-56","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/021087s056_021246s039lbl.pdf\"}]","notes":""},{"actionDate":"02\/07\/2011","submission":"SUPPL-57","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/021087s057lbl.pdf\"}]","notes":""},{"actionDate":"12\/15\/2010","submission":"SUPPL-45","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2010\\\/021087s045,021246s031lbl.pdf\"}]","notes":""},{"actionDate":"11\/05\/2010","submission":"SUPPL-55","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2010\\\/021087s055lbl.pdf\"}]","notes":""},{"actionDate":"02\/22\/2010","submission":"SUPPL-49","supplementCategories":"Efficacy-New Dosing Regimen","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2010\\\/021087s048s049,021246s034s035lbl.pdf\"}]","notes":""},{"actionDate":"02\/22\/2010","submission":"SUPPL-48","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2010\\\/021087s048s049,021246s034s035lbl.pdf\"}]","notes":""},{"actionDate":"09\/25\/2008","submission":"SUPPL-47","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"\"}]","notes":""},{"actionDate":"01\/17\/2008","submission":"SUPPL-42","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2008\\\/021087s042,021246s030lbl.pdf\"}]","notes":""},{"actionDate":"10\/05\/2007","submission":"SUPPL-41","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2007\\\/021087s041,021246s028lbl.pdf\"}]","notes":""},{"actionDate":"07\/02\/2007","submission":"SUPPL-40","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"\"}]","notes":""},{"actionDate":"07\/02\/2007","submission":"SUPPL-40","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"\"}]","notes":""},{"actionDate":"11\/13\/2006","submission":"SUPPL-33","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2006\\\/021087s033lbl.pdf\"}]","notes":""},{"actionDate":"12\/21\/2005","submission":"SUPPL-30","supplementCategories":"Efficacy-New Patient Population","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2005\\\/021246s017_021087s030lbl.pdf\"}]","notes":""},{"actionDate":"10\/27\/2005","submission":"SUPPL-25","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2005\\\/021087s025lbl.pdf\"}]","notes":""},{"actionDate":"08\/16\/2005","submission":"SUPPL-26","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2005\\\/021087s026lbl.pdf\"}]","notes":""},{"actionDate":"04\/20\/2005","submission":"SUPPL-23","supplementCategories":"Manufacturing (CMC)-Packaging","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2005\\\/021087s023lbl.pdf\"}]","notes":""},{"actionDate":"06\/24\/2004","submission":"SUPPL-16","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2004\\\/21087slr016,21246slr010_Tamiflu_lbl.pdf\"}]","notes":""},{"actionDate":"04\/26\/2002","submission":"SUPPL-10","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2002\\\/21087S10lbl_update.pdf\"}]","notes":""},{"actionDate":"11\/05\/2001","submission":"SUPPL-9","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2001\\\/21087s9lbl.pdf\"}]","notes":""},{"actionDate":"07\/24\/2001","submission":"SUPPL-8","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2001\\\/21087s8lbl.pdf\"}]","notes":""},{"actionDate":"07\/24\/2001","submission":"SUPPL-6","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2001\\\/21087s5s6lbl.pdf\"}]","notes":""},{"actionDate":"07\/24\/2001","submission":"SUPPL-5","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2001\\\/21087s5s6lbl.pdf\"}]","notes":""},{"actionDate":"11\/17\/2000","submission":"SUPPL-2","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2000\\\/21087S002lbl.pdf\"}]","notes":""},{"actionDate":"10\/27\/1999","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/1999\\\/21087lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"TAMIFLU","submission":"OSELTAMIVIR PHOSPHATE","actionType":"EQ 75MG BASE","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"TAMIFLU","submission":"OSELTAMIVIR PHOSPHATE","actionType":"EQ 45MG BASE","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"TAMIFLU","submission":"OSELTAMIVIR PHOSPHATE","actionType":"EQ 30MG BASE","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2019-08-02
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.